Comparative Analysis of the Interaction of Silver Nanoparticles with Hexokinase from Trypanosoma brucei and Humans

References

• Truc P, Lando A, Penchenier L, et al. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. Trans R Soc Trop Med Hyg. 2012;106(1):10–14.
   PubMed Web of Science ®Google Scholar
• Simarro PP, Jannin J, Cattand P. Eliminating human African trypanosomiasis: where do we stand and what comes next. PLoS Med. 2008;5(2):e55. doi:10.1371/journal.pmed.0050055
   PubMed Web of Science ®Google Scholar
• Koagne TL, M’eyi MP, Kamkuimo RG, et al. Transmission of human African trypanosomiasis in the Komo-Mondah focus, Gabon. Pan Aft. 2011;8:36.
   PubMedGoogle Scholar
• Baker N, de Koning HP, Mäser P, et al. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol. 2013;29(3):110–118. doi:10.1016/j.pt.2012.12.005
   PubMed Web of Science ®Google Scholar
• Albert MA, Haanstra JR, Hannaert V, et al. Experimental and in silico analyses of glycolytic flux control in bloodstream form trypanosoma brucei. J. Biol. Chem. 2005;280(5):28306–28315. doi:10.1074/jbc.M502403200
   PubMedGoogle Scholar
• Lyda T. Exploring Trypanosoma Brucei Hexokinase Biology, Localization and Inhibition Studies, Graduate School of Clemson University. [DPhil Thesis]; 2009. Available from www.etd.lib.Clemson.edu/document/1263396314/lyda_clemson/0050d/10416.pdf. Accessed May 28, 2012.
   Google Scholar
• Chambers JW, Fowler ML. The antitrypanosomal agents lonidamine inhibit trypanosoma brucei hexokinase 1. Mol Biol Para. 2008;158:202–207. doi:10.1016/j.molbiopara.2007.12.013
   PubMed Web of Science ®Google Scholar
• Joice AC, Harris MT, Kahney EW. Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition. Int J Parasitol. 2013;3:154–160. doi:10.1016/j.ijpddr.2013.08.002
   Web of Science ®Google Scholar
• Sadanandan N. Nanomedicine-The basics. West London Med J. 2011;3(3):11–14.
   Google Scholar
• Driskell JD, Jones CA, Tompkins SM, et al. One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. Analyst. 2011;136:3083.
   PubMed Web of Science ®Google Scholar
• Bonanni A, Pividori MI, Valle M. Impedimetric detection of influenza A (H1N1) DNA sequence using carbon nanotubes platform and gold nanoparticle amplification. Carb Nano. 2010;135:1765–1772.
   Google Scholar
• Samra Q, Ahmad S, Javeid M, et al. Anticancer medicine (Doxorubicin and Methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron. Prep. Biochem. Biotech. 2013;43(8):781797. doi:10.1080/10826068.2013.782042
   Web of Science ®Google Scholar
• Block O, Mitra A, Novotny L, et al. A rapid label-free method for quantitation of human immunodeficiency virus type-1 particles by nanospectroscopy. J. of Virol. Meth. 2012;182(1–2):70–75. doi:10.1016/j.jviromet.2012.03.012
   PubMed Web of Science ®Google Scholar
• Nguyen KT. Photothermal Therapy and Nanomaterials. J Bioeng Biomed Sci. 2012;2(4):e1122. doi:10.4172/2155-9538.1000e112
   Google Scholar
• Khan M, Karuppiah P, Alkhathlan HZ, et al. Green synthesis of silver nanoparticles using Juniperus procera extract: their characterization, and biological activity. Crystals. 2022;12:420. doi:10.3390/cryst12030420
   Web of Science ®Google Scholar
• Asimuddin M, Mohamed RS, Fathima N, et al. Study of antibacterial properties of Ziziphus mauritiana based green synthesized silver nanoparticles against various bacterial strains. Sustain. 2020;12:1484. doi:10.3390/su12041484
   Web of Science ®Google Scholar
• Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, et al. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotech. 2010;l8:1–10. doi:10.1186/1477-3155-8-1
   Google Scholar
• Xiang D, Chen Q, Pang L, et al. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Viro l Meth. 2011;178(1–2):137142.
   Web of Science ®Google Scholar
• Sennuga AT. Biological Synthesis of Metallic Nanoparticles and their Interactions with Various Biomedical Targets. [PhD Thesis]. Rhodes. Available from; http://eprints.ru.ac.za/3049/. Accessed August 15, 2012.
   Google Scholar
• Adeyemi OS, Whiteley CG. Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei; thermodynamic and spectrophotometric evaluation. J Biochimica Biophys Acta-Gen Sub. 2013;1840(1):701–706. doi:10.1016/j.bbagen.2013.10.038
   PubMed Web of Science ®Google Scholar
• De Moor W, Van Marwijk J, Wilhelmi BS, et al. Interaction of silver nanoparticles with triosephosphate isomerase from human and malarial parasite (Plasmodium falciparum): a comparative study. J Biomed Nanotechnol. 2015;11(6):1071–1079. doi:10.1166/jbn.2015.2003
   PubMed Web of Science ®Google Scholar
• Padayachee ER, Arowolo A, Whiteley CG. Nanomedicine: action of metal nanoparticles on neuronal nitric oxide synthase-fluorometric analysis on the mechanism for fibrillogenesis. J Neurochem Res. 2013;39:194–201. doi:10.1007/s11064-013-1206-x
   PubMed Web of Science ®Google Scholar
• Jayachandran P, Ilango S, Suseela V, et al. Green synthesized silver nanoparticle-loaded liposome-based nanoarchitectonics for cancer management: in vitro drug release analysis. Biomed. 2023;11:217.
   Google Scholar
• Dykman LA, Khlebtsov NG. Gold nanoparticles in Biology and Medicine. Rec Adv Prosp Europe. 2011;3(9):34–55.
   Google Scholar
• Liu C, Yang X, Yuan H, et al. Preparation of silver nanoparticle and its application to the determination of ct-DNA. Sensors. 2013;2013:708718.
   Google Scholar
• Shen W, Feng L, Feng H, et al. Ultrafine silver (II) oxide particles decorated porous ceramic composites for water treatment. J of Chem. Eng. 2011;175:592–599. doi:10.1016/j.cej.2011.09.121
   Google Scholar
• Johannessen CM, Boehm JS, Kim SY, et al. COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nat. 2010;468(7326):968–972. doi:10.1038/nature09627
   Google Scholar
• Pal A, Shah S, Devi S. Microwave-assisted synthesis of silver nanoparticles using ethanol as a reducing agent. Mat Chem Phys. 2009;114:30–532. doi:10.1016/j.matchemphys.2008.11.056
   Web of Science ®Google Scholar
• Hanahan D, Harbor CS. Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983;166:557–580. doi:10.1016/S0022-2836(83)80284-8
   PubMed Web of Science ®Google Scholar
• Singh M, Singh S, Prasad S¸et al. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. J Nano Biostr. 2009;3(3):115–122.
   Web of Science ®Google Scholar
• Hsu SL, Chung WU, Tarng R. Preparation of silver nanoparticle with different particle sizes for low- temperature sintering. Int Conf on Nanotech and Biosens. 2011;2:55–58.
   Google Scholar
• Tiedge M, Richter T, Lenzen S. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Arch Biochem Biophys. 2000;375(2):251–260. doi:10.1006/abbi.1999.1666
   PubMed Web of Science ®Google Scholar
• Bigon E, Boarato E, Bruni A, et al. Pharmacological effects of phosphatidylserine liposomes: regulation of glycolysis and energy level in brain. Br. J. Pharmacol. 1979;(1979(66):167–174. doi:10.1111/j.1476-5381.1979.tb13661.x
   Google Scholar
• Odika IE, Asuzu IU, Anika SM. The effects of hyperosmolar agents lithium chloride and sucrose on the brain concentration of diminazene aceturate in rats. Acta Trop. 1995;60:119–125.
   PubMed Web of Science ®Google Scholar
• Troster SD, Muller U, Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants, Int. J Pharm. 1990;61:85–100.
   Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev. 2001;47:65–81. doi:10.1016/S0169-409X(00)00122-8
   PubMed Web of Science ®Google Scholar
• Olbrich C, Gessner A, Schröder W, et al. Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption. J Control Release. 2004;96(3):425–435. doi:10.1016/j.jconrel.2004.02.024
   PubMed Web of Science ®Google Scholar
• Croft SL. Pharmacological approaches to antitrypanosomal chemotherapy. Memórias Do Instituto Oswaldo Cruz. 1999;94(2):215–220. doi:10.1590/S0074-02761999000200017
   PubMed Web of Science ®Google Scholar
• Byrne MM, Sturis J, Clément K, et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest. 1994;93(3):1120–1130. doi:10.1172/JCI117064
   PubMed Web of Science ®Google Scholar
• Matschinsky FM, Porte D. Glucokinase activators (GKAs) promise a new pharmacotherapy for diabetics. F1000 med Rep. 2010;2::12–16. doi:10.3410/M2-43
   PubMedGoogle Scholar
• Angadi KK, Gundampati RK, Jagannadham MV, et al. Molecular docking studies of guggultetrol from Nymphaea pubescens with target glucokinase (GK) related to type-II Diabetes. Sci. 2013;3(2):127–131.
   Google Scholar
• Liu C, Yang X, Yuan H, et al. Preparation of silver nanoparticle and its application to the determination of ct-DNA. Sensors. 2007;2007:708–718.
   Google Scholar
• Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric NPs in diabetic rats. J Cont Rel. 2007;117(2):163–170. doi:10.1016/j.jconrel.2006.10.023
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Jain AK, et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release. 2007;122(2):141–150. doi:10.1016/j.jconrel.2007.05.019
   PubMed Web of Science ®Google Scholar
• Mishra M, Kumar H, Tripathi K. Diabetic delayed wound healing and the role of silver. J of Nano. 2008;3(2):49–54.
   Google Scholar